Amway invests $4Mn in four research labs across India

Amway’s four state-of-the-art R&D labs in Gurugram, Chennai, Bengaluru and Dindigul

Amway, a global company, formally introduced its four state-of-the-art Research & Development (R&D) labs across India with an investment of $4 million. By harnessing advanced technology, contemporary science and thought leadership, these labs are poised to redefine industry standards by developing safe, effective, differentiated and high-quality health and wellbeing products to support people in India and around the world. India is the location of one of the four Amway R&D hubs, worldwide. This strategic move is in line with Amway’s efforts to cater to the evolving needs of consumers empowering millions to achieve optimal wellbeing and fostering a healthier future for all.

Amway’s four state-of-the-art R&D labs in Gurugram, Chennai, Bengaluru and Dindigul collectively total 24,700 square feet, creating a powerhouse of scientific discovery and breakthrough product development.

Talking about the investment from Amway India’s business perspective and describing the benefits to India, Rajneesh Chopra, Managing Director, of Amway India, said “There is a need for a transformative approach to nutrition and wellness in India, as the health landscape here faces significant challenges related to nutrition, lifestyle and gut health. This investment accelerates Amway India’s product development capabilities and positions Amway to better serve the unique and evolving needs of its consumers and businesses in India and around the world. India stands as one of our top priority markets globally and this investment underscores the confidence of Amway Global in the country’s expertise and potential to drive groundbreaking innovation in the health and wellbeing space.”